Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C A M de Haan

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Advances in Virus Research|October 8, 2016
Coronavirus Spike Protein and Tropism ChangesR J G Hulswit, C A M de Haan, B-J Bosch
Journal of Virology|February 14, 2006
Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and MM Oostra, C A M de Haan, R J de Groot, et al.
Vaccine|July 29, 2014
Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigenN Oreshkova, L A H M Cornelissen, C A M de Haan, et al.
Journal of Virology|June 24, 2011
Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicityI N Ambepitiya Wickramasinghe, R P de Vries, A Gröne, et al.
Journal of Virology|September 15, 2007
Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replicationM Oostra, E G te Lintelo, M Deijs, et al.
Journal of Virology|January 18, 2006
Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapterM H Verheije, T Würdinger, V W van Beusechem, et al.
Journal of Virology|September 28, 2012
Heparan sulfate facilitates Rift Valley fever virus entry into the cellS M de Boer, J Kortekaas, C A M de Haan, et al.
Journal of Virology|April 11, 2008
Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptationC A M de Haan, B J Haijema, P Schellen, et al.
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Journal of Virology|November 24, 2017
Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of InfluenzaE R Job, M Schotsaert, L I Ibañez, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Advances in Virus Research|October 8, 2016
Coronavirus Spike Protein and Tropism ChangesR J G Hulswit, C A M de Haan, B-J Bosch
Journal of Virology|February 14, 2006
Glycosylation of the severe acute respiratory syndrome coronavirus triple-spanning membrane proteins 3a and MM Oostra, C A M de Haan, R J de Groot, et al.
Vaccine|July 29, 2014
Evaluation of nonspreading Rift Valley fever virus as a vaccine vector using influenza virus hemagglutinin as a model antigenN Oreshkova, L A H M Cornelissen, C A M de Haan, et al.
Journal of Virology|June 24, 2011
Binding of avian coronavirus spike proteins to host factors reflects virus tropism and pathogenicityI N Ambepitiya Wickramasinghe, R P de Vries, A Gröne, et al.
Journal of Virology|September 15, 2007
Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replicationM Oostra, E G te Lintelo, M Deijs, et al.
Journal of Virology|January 18, 2006
Redirecting coronavirus to a nonnative receptor through a virus-encoded targeting adapterM H Verheije, T Würdinger, V W van Beusechem, et al.
Journal of Virology|September 28, 2012
Heparan sulfate facilitates Rift Valley fever virus entry into the cellS M de Boer, J Kortekaas, C A M de Haan, et al.
Journal of Virology|April 11, 2008
Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptationC A M de Haan, B J Haijema, P Schellen, et al.
Gene Therapy|April 22, 2005
Targeting non-human coronaviruses to human cancer cells using a bispecific single-chain antibodyT Würdinger, M H Verheije, M Raaben, et al.
Journal of Virology|November 24, 2017
Antibodies Directed toward Neuraminidase N1 Control Disease in a Mouse Model of InfluenzaE R Job, M Schotsaert, L I Ibañez, et al.
Pageof 2